Nuclear medicine, Malmö
21 – 30 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Biokinetics and dosimetry of 18F-PSMA-1007 in patients with prostate cancer
- Contribution to journal › Article
-
Mark
Detection of lymph node metastases in patients with prostate cancer : Comparing conventional and digital [18F]-fluorocholine PET-CT using histopathology as a reference
- Contribution to journal › Article
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
- Contribution to journal › Article
-
Mark
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer
- Contribution to journal › Article
- 2021
-
Mark
Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11
- Contribution to journal › Article
-
Mark
Artificial intelligence-based detection of lymph node metastases by PET/CT predicts prostate cancer-specific survival
- Contribution to journal › Article
-
Mark
Dose-reduced [18F]PSMA-1007 PET is feasible for functional imaging of the renal cortex
- Contribution to journal › Article
-
Mark
Artificial intelligence-based measurements of PET/CT imaging biomarkers are associated with disease-specific survival of high-risk prostate cancer patients
- Contribution to journal › Article
-
Mark
Automated artificial intelligence-based analysis of skeletal muscle volume predicts overall survival after cystectomy for urinary bladder cancer
- Contribution to journal › Article
-
Mark
Post-reconstruction enhancement of [18F]FDG PET images with a convolutional neural network
- Contribution to journal › Article
